Alteration in Expression of miR-32 and FBXW7 Tumor Suppressor in Plasma Samples of Patients with T-cell Acute Lymphoblastic Leukemia
Sanaz Mansouri,1,* Behzad Khansarinejad,2,* Ghasem Mosayebi,2 Aziz Eghbali,3 Mahdieh Mondanizadeh1,4 1Department of Biotechnology and Molecular Medicine, Arak University of Medical Sciences, Arak, Iran; 2Department of Microbiology and Immunology, Arak University of Medical Sciences, Arak, Iran; 3Dep...
Main Authors: | Mansouri S, Khansarinejad B, Mosayebi G, Eghbali A, Mondanizadeh M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-02-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/alteration-in-expression-of-mir-32-and-fbxw7-tumor-suppressor-in-plasm-peer-reviewed-article-CMAR |
Similar Items
-
MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma
by: Nilmary Grafals-Ruiz, et al.
Published: (2023-09-01) -
Changes in Expression of miR-1297 and PTEN Tumor Suppressor Gene in T-cell Acute Lymphoblastic Leukemia
by: Malihe Bagheri, et al.
Published: (2021-01-01) -
Tumor Suppressor FBXW7 and Its Regulation of DNA Damage Response and Repair
by: Huiyin Lan, et al.
Published: (2021-10-01) -
Knockdown of lincRNA PADNA promotes bupivacaine-induced neurotoxicity by miR-194/FBXW7 axis
by: Fan Yuning, et al.
Published: (2020-08-01) -
Clinical significance of FBXW7 tumor suppressor gene mutations and expression in human colorectal cancer: a systemic review and meta-analysis
by: Wei Shang, et al.
Published: (2021-07-01)